reproduced verbatim): Maternal drug abuse places hundreds of thousands of progeny at risk each year in the United States. This problem has become more severe recently, due to the greater availability of purer heroin and an increase in young abusers. The effect of opioids on mitogenic pathways in the fetus of drug-addicted mothers may contribute to the physiological and psychological delays observed in their offspring. Glial cell proliferation plays an integral role in normal brain development. Opioids modulate mitogenic signaling in astrocytes from developing brain. The broad goal of our research is to delineate mechanisms involved in opioid modulation of mitogen-mediated glial cell growth and differentiation. Our previous studies disclosed major features of the mechanism of the mitogenic action of an agonist of the endogenous kappa OR in C6 glioma cells, an astrocytic model system. Evidence for both receptor endocytosis-dependent and -independent opioid mitogenic signaling has been discovered. The particular focus of this application is to delineate how and where in the cell opioid and RTK signaling converge to modulate proliferation of primary astrocytes from perinatal brain of various ages. There are three specific aims:
AIM 1) Identify the point of convergence between opioid and mitogenic signaling pathways upstream of the MAP kinase cascade in primary astrocytes.
AIM 2) Test the hypothesis that opioid receptor internalization is required to """"""""switch"""""""" opioid signal transduction to a MAP kinase-modulating mode for mitogens.
AIM 3) Test the hypothesis that mitogenic signaling component(s) are desensitized upon chronic exposure to opioids that attenuate mitogen-induced proliferation of astrocytes. We will use biochemical, immunological, recombinant protein and other molecular biological techniques to study opioid signaling in primary astrocytes. The answers sought in these mechanistic studies have fundamental significance, and also bear on the important public health problem of maternal drug abuse. They may also have implications for understanding some aspects of AIDS dementia.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA005412-12
Application #
6497783
Study Section
Special Emphasis Panel (ZRG1-MDCN-6 (01))
Program Officer
Riddle, Robert D
Project Start
1987-09-30
Project End
2004-01-31
Budget Start
2002-02-01
Budget End
2004-01-31
Support Year
12
Fiscal Year
2002
Total Cost
$259,000
Indirect Cost
Name
Saint Louis University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
City
Saint Louis
State
MO
Country
United States
Zip Code
63103
Ikeda, Hiroko; Miyatake, Mayumi; Koshikawa, Noriaki et al. (2010) Morphine modulation of thrombospondin levels in astrocytes and its implications for neurite outgrowth and synapse formation. J Biol Chem 285:38415-27
Hahn, Jason W; Jagwani, Shana; Kim, Eunhae et al. (2010) Mu and kappa opioids modulate mouse embryonic stem cell-derived neural progenitor differentiation via MAP kinases. J Neurochem 112:1431-41
Miyatake, Mayumi; Rubinstein, Tal J; McLennan, Gregory P et al. (2009) Inhibition of EGF-induced ERK/MAP kinase-mediated astrocyte proliferation by mu opioids: integration of G protein and beta-arrestin 2-dependent pathways. J Neurochem 110:662-74
McLennan, Gregory P; Kiss, Alexi; Miyatake, Mayumi et al. (2008) Kappa opioids promote the proliferation of astrocytes via Gbetagamma and beta-arrestin 2-dependent MAPK-mediated pathways. J Neurochem 107:1753-65
Kim, Eunhae; Clark, Amy L; Kiss, Alexi et al. (2006) Mu- and kappa-opioids induce the differentiation of embryonic stem cells to neural progenitors. J Biol Chem 281:33749-60
Belcheva, Mariana M; Clark, Amy L; Haas, Paul D et al. (2005) Mu and kappa opioid receptors activate ERK/MAPK via different protein kinase C isoforms and secondary messengers in astrocytes. J Biol Chem 280:27662-9
Belcheva, Mariana M; Tan, Yun; Heaton, Virginia M et al. (2003) Mu opioid transactivation and down-regulation of the epidermal growth factor receptor in astrocytes: implications for mitogen-activated protein kinase signaling. Mol Pharmacol 64:1391-401
Belcheva, Mariana M; Haas, Paul D; Tan, Yun et al. (2002) The fibroblast growth factor receptor is at the site of convergence between mu-opioid receptor and growth factor signaling pathways in rat C6 glioma cells. J Pharmacol Exp Ther 303:909-18
Fabian, G; Bozo, B; Szikszay, M et al. (2002) Chronic morphine-induced changes in mu-opioid receptors and G proteins of different subcellular loci in rat brain. J Pharmacol Exp Ther 302:774-80
Belcheva, Mariana M; Coscia, Carmine J (2002) Diversity of G protein-coupled receptor signaling pathways to ERK/MAP kinase. Neurosignals 11:34-44

Showing the most recent 10 out of 27 publications